Characterization of pulmonary progenitor cell dysfunction in COPA syndrome
Characterization of pulmonary progenitor cell dysfunction in COPA syndrome
批准号:
10473891
负责人:
Colin Koziol
金额:
$3.89万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-01 至 2023-08-31
关键词:
AffectAllelesAlveolarAnti-Inflammatory AgentsAutoantibodiesAutoimmuneAutoimmunityAutomobile DrivingAutophagocytosisBronchiolitisCRISPR/Cas technologyCarrier ProteinsCell physiologyCellsCellular StressCharacteristicsChronicClinicalCoatomer ProteinCodeComplexConsensusDefectDevelopmentDiseaseDisease ManagementDisease PathwayDistalDominant-Negative MutationEctopic ExpressionEpithelialEpithelial CellsFibroblastsFibrosisFunctional disorderGasesGene TransferGenesGolgi ApparatusImmuneImmune responseImmune systemIn VitroInflammationInflammatory ResponseIntentionInterstitial Lung DiseasesJointsLeadLentivirus VectorLifeLinkLocationLungLung diseasesMaintenanceMendelian disorderMissense MutationMusMutationNasal EpitheliumOrganPathogenicityPathologicPathologyPathway interactionsPatientsPenetrancePharmaceutical PreparationsPhenotypePopulationPropertyProtein SubunitsProteinsPulmonary FibrosisPulmonary alveolar structureRoleSamplingSecretory CellSignal TransductionSolidSpecialized Epithelial CellSymptomsSyndromeSystemTestingTissue-Specific Gene ExpressionVesicleWD Repeatalveolar type II cellbiological adaptation to stresscell typedelivery vehicledisease phenotypeendoplasmic reticulum stressfunctional disabilitygain of functionidiopathic pulmonary fibrosisimmune activationin vivoinduced pluripotent stem cellinflammatory markermouse modelmutantnovelnovel therapeutic interventionprogenitorprotein complexpulmonary functionreduce symptomsrepairedresponseresponse to injuryretrograde transportsingle-cell RNA sequencingsomatic cell gene editingstem cell functionstem cellstherapeutic targettooltranscriptome
中文摘要
项目摘要-摘要
COPA综合征是一种罕见的常染色体显性单基因遗传病。
导致一种影响肺部和关节的不完全外露的多器官疾病。患者提早就诊
患有间质性肺病(ILD),并有炎症标志物升高和自身抗体滴度阳性的患者。
虽然存在控制这种异常免疫表型的治疗方法,但它们不能解决未知的问题。
本病发病机制(S)。COPalpha是辅酶蛋白复合体I的一个普遍表达的亚基
(COPI)负责将蛋白质从高尔基体逆行运输到内质网。更改或更改
这一途径的中断会导致细胞应激。到目前为止,大多数研究都考察了免疫的作用。
在COPA综合征的发生和发展过程中没有阐明这种疾病的原因的系统。因此,
我们认为这涉及到其他类型的细胞和过程。大多数COPA患者在某个时候会患上
肺部疾病,如毛细支气管炎、ILD和/或肺纤维化(PF)。这些疾病共有
响应细胞应激的某些致病特性,包括但不限于,内质网应激和
未折叠蛋白反应(UPR)激活、成纤维细胞激活、炎症和异常自噬。
肺近端和远端的祖细胞、基底细胞和肺泡II型细胞(ATII)分别是
不成比例地受到影响,导致整个呼吸道上皮的异常维持。我们相信
类似的祖细胞功能障碍机制也发生在COPA综合征患者中。因此,我们
假设COPA综合征是由先天祖细胞缺陷引起的
上皮维持导致ILD和肺纤维化。在目标1中,我们将确定上皮细胞-
COPAMT基因表达导致的固有缺陷。这将通过表征COPalpha相互作用组来阐明导致细胞应激的异常蛋白质相互作用来实现。然后,我们将描述
单细胞RNA测序筛选COPAMT转录组差异基因表达谱
与疾病相关的。此外,我们将利用活体小鼠模型来准确描述这种联系
肺祖细胞功能障碍与COPA相关免疫反应激活的关系
综合症。在目标2中,我们将验证挽救COPA综合征上皮细胞缺陷的策略
慢病毒载体传递系统和基因编辑工具,目的是挽救患病的表型。
英文摘要
PROJECT SUMMARY – ABSTRACT
Coatomer protein subunit alpha (COPA) syndrome is a rare, autosomal dominant, monogenic disorder that
results in a multiorgan disease affecting the lungs and joints with incomplete penetrance. Patients present early
in life with interstitial lung disease (ILD) and have elevated inflammatory markers and positive autoantibody titers.
While treatments exist to control this aberrant immune phenotype, they do not address the unknown
mechanism(s) of this disease. COPalpha is a ubiquitously expressed subunit of the coatomer protein complex I
(COPI) which is responsible for retrograde transport of proteins from the Golgi to the ER. Alterations or
disruptions in this pathway result in cellular stress. To date, most studies have examined the role of the immune
system in the onset and progression of COPA syndrome without elucidating a cause for this disease. Therefore,
we believe other cell types and processes are involved. Most COPA patients will at some point suffer from a
spectrum of pulmonary disease such as bronchiolitis, ILD, and/or pulmonary fibrosis (PF). These diseases share
certain pathogenic characteristics in response to cellular stress including, but not limited to, ER stress and
unfolded protein response (UPR) activation, activated fibroblasts, inflammation, and aberrant autophagy.
Progenitor cells of the proximal and distal lung, basal and alveolar type II cells (ATII), respectively, are
disproportionally affected causing aberrant maintenance of the epithelium throughout the airway. We believe
similar mechanisms of progenitor cell dysfunction are occurring in COPA syndrome patients. We therefore
hypothesize that COPA syndrome is driven by an intrinsic progenitor cell defect that compromises
epithelial maintenance resulting in ILD and lung fibrosis. In Aim 1, we will determine the epithelial cell-
intrinsic defects resulting from the expression of COPAMT. This will be achieved by characterizing the COPalpha interactome to elucidate anomalous protein interactions leading to cellular stress. We will then characterize the
transcriptome of COPAMT using single cell RNA sequencing to highlight differential gene expression patters
associated with disease. Furthermore, we will utilize in vivo mouse models to accurately describe the link
between pulmonary progenitor cell dysfunction and activation of the immune responses associated with COPA
syndrome. In Aim 2, we will validate strategies to rescue the epithelial cell defect of COPA syndrome using
lentiviral vector delivery systems and gene editing tools with the intention of rescuing the diseased phenotype.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization of pulmonary progenitor cell dysfunction in COPA syndrome
-
批准号:10364622
-
项目类别:
-
资助金额:$3.82万
-
财政年份:2020
-
负责人:Colin Koziol
-
依托单位:
海外基金